![Novo's next-gen GLP-1 Ozempic smashes blockbuster barrier amid ramp-up for Rybelsus rollout | Fierce Pharma Novo's next-gen GLP-1 Ozempic smashes blockbuster barrier amid ramp-up for Rybelsus rollout | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1580914062/LarsFruegaardJorgensen.jpg/LarsFruegaardJorgensen.jpg?VersionId=.opABATyKCrW.Lf8eKoL55dJGLyGIjc3)
Novo's next-gen GLP-1 Ozempic smashes blockbuster barrier amid ramp-up for Rybelsus rollout | Fierce Pharma
![With new Medtronic pact, Novo Nordisk's smart insulin pen to link with all major CGMs | Fierce Biotech With new Medtronic pact, Novo Nordisk's smart insulin pen to link with all major CGMs | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1568641565/novonordiskflagfly.jpg/novonordiskflagfly.jpg?VersionId=Vi2ZYkRq.VvtngwFRgIdocXduVBg7jnq)
With new Medtronic pact, Novo Nordisk's smart insulin pen to link with all major CGMs | Fierce Biotech
![Damcos / Danfoss /Nordisk Marine Hydraulik A/S Hydraulic Gear Pump W3 A/B1 2.0 CCM RIGHT Part # INT-1896 | Damcos Parts Damcos / Danfoss /Nordisk Marine Hydraulik A/S Hydraulic Gear Pump W3 A/B1 2.0 CCM RIGHT Part # INT-1896 | Damcos Parts](https://damcosmarineparts.com/wp-content/uploads/2019/11/compressed_20190904_163509.jpg)
Damcos / Danfoss /Nordisk Marine Hydraulik A/S Hydraulic Gear Pump W3 A/B1 2.0 CCM RIGHT Part # INT-1896 | Damcos Parts
![NOVO NORDISK: FDA approves Fiasp® for use in insulin infusion pumps for adults with type 1 or type 2 diabetes | FDA Health News NOVO NORDISK: FDA approves Fiasp® for use in insulin infusion pumps for adults with type 1 or type 2 diabetes | FDA Health News](https://s3.amazonaws.com/jnswire/jns-media/da/0a/4455260/Fiasp.png)
NOVO NORDISK: FDA approves Fiasp® for use in insulin infusion pumps for adults with type 1 or type 2 diabetes | FDA Health News
![A view shows an insulin production line at Novo Nordisk's plant in Kalundborg November 4, 2013. Picture taken November 4, 2013. Novo Nordisk's Kalundborg factory, 100 km west of Copenhagen, makes half A view shows an insulin production line at Novo Nordisk's plant in Kalundborg November 4, 2013. Picture taken November 4, 2013. Novo Nordisk's Kalundborg factory, 100 km west of Copenhagen, makes half](https://c8.alamy.com/comp/2D02C7E/a-view-shows-an-insulin-production-line-at-novo-nordisks-plant-in-kalundborg-november-4-2013-picture-taken-november-4-2013-novo-nordisks-kalundborg-factory-100-km-west-of-copenhagen-makes-half-the-planets-insulin-for-diabetics-putting-it-on-a-list-of-global-sites-the-united-states-sees-as-vital-to-its-interests-according-to-a-wikileaks-cable-in-2010-soaring-diabetes-rates-driven-by-increasing-obesity-have-fuelled-profits-at-the-danish-company-for-two-decades-but-now-the-company-wants-to-tackle-obesity-head-on-by-launching-a-treatment-specifically-to-help-patients-lose-weight-to-2D02C7E.jpg)